Analysts provide stock recommendations for Precigen Inc (PGEN)

Precigen Inc (NASDAQ: PGEN) closed the day trading at $1.30 down -4.74% from the previous closing price of $1.37. In other words, the price has decreased by -$0.0650 from its previous closing price. On the day, 1415525 shares were traded. PGEN stock price reached its highest trading level at $1.4100 during the session, while it also had its lowest trading level at $1.2500.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.


For a better understanding of PGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 28 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.

KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 324.84M and an Enterprise Value of 258.48M. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.05 while its Price-to-Book (P/B) ratio in mrq is 2.27. Its current Enterprise Value per Revenue stands at 38.24 whereas that against EBITDA is -3.35.

Stock Price History:

Over the past 52 weeks, PGEN has reached a high of $2.29, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is 1.2098, while the 200-Day Moving Average is calculated to be 1.2589.

Shares Statistics:

Over the past 3-months, PGEN traded about 1.42M shares per day on average, while over the past 10 days, PGEN traded about 1.42M shares per day. A total of 208.15M shares are outstanding, with a floating share count of 125.14M. Insiders hold about 49.73% of the company’s shares, while institutions hold 24.47% stake in the company. Shares short for PGEN as of Dec 28, 2023 were 17.99M with a Short Ratio of 17.99M, compared to 18.15M on Nov 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.23% and a Short% of Float of 12.18%.

Earnings Estimates

Current recommendations for the stock of the company come from 4 analysts. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.08, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.33 and -$0.41 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.31, with 4 analysts recommending between -$0.25 and -$0.39.

Revenue Estimates

A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $7.5M, while the lowest revenue estimate was $5M, resulting in an average revenue estimate of $6.7M. In the same quarter a year ago, actual revenue was $26.91M, down -75.10% from the average estimate.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular